- 专利标题: METHOD FOR PRODUCING CELL POPULATION THAT INCLUDES MESENCHYMAL STEM CELLS, MESENCHYMAL STEM CELLS, CELL POPULATION, AND PHARMACEUTICAL COMPOSITION
-
申请号: EP16859885.2申请日: 2016-10-27
-
公开(公告)号: EP3369810A1公开(公告)日: 2018-09-05
- 发明人: YAMAHARA, Kenichi , KITA, Yuta , INO, Keita , KOBAYASHI, Akira
- 申请人: Kaneka Corporation , National Cerebral and Cardiovascular Center
- 申请人地址: 3-18, Nakanoshima 2-chome Kita-ku Osaka-shi, Osaka 530-8288 JP
- 专利权人: Kaneka Corporation,National Cerebral and Cardiovascular Center
- 当前专利权人: Kaneka Corporation,National Cerebral and Cardiovascular Center
- 当前专利权人地址: 3-18, Nakanoshima 2-chome Kita-ku Osaka-shi, Osaka 530-8288 JP
- 代理机构: Hoffmann Eitle
- 优先权: JP2015211051 20151027
- 国际公布: WO2017073656 20170504
- 主分类号: C12N5/0775
- IPC分类号: C12N5/0775 ; A61K35/28 ; A61P1/04 ; A61P1/16 ; A61P9/10 ; A61P17/06 ; A61P37/02
摘要:
The object of the present invention is to provide a method for producing a cell population comprising mesenchymal stem cells having a high specific growth rate which are useful for promptly producing large amounts of cell formulations. The present invention provides a method for producing a cell population comprising mesenchymal stem cells, comprising: a step of treating a cell population comprising mesenchymal stem cells having different proliferative ability by physical stimulation or chemical stimulation, so as to select mesenchymal stem cells having relatively high proliferative ability, wherein the selected mesenchymal stem cells having relatively high proliferative ability are negative for CD106, and the expression level of a metallothionein family gene is increased in comparison to the expression level thereof in the cell population before the treatment by the physical stimulation or chemical stimulation.
信息查询
IPC分类: